A stepwise transduction of mutated RUNX1 followed by BMI1 overexpression in human CD34+ cells results in long-term CD34+ progenitor cell proliferation with a retained CD34+ cell fraction similar to the phenotype observed in patients with higher risk MDS (Harada et al., 2013). The gene discussed is CD34; the disease is myelodysplastic syndrome.